UNSPSC 85819114: Transfusion of autologous serum albumin into peripheral artery, percutaneous approach

This classification denotes the group of activities that yields a surgical intervention or procedure to transfusion of autologous serum albumin into peripheral artery, percutaneous approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 30253J0

UNSPSC 85819114, Transfusion of autologous serum albumin into peripheral artery, percutaneous approach, is a Commodity code showing minimal alignment with recent state and local procurement activity. The code nominally describes a specific clinical procedure—infusion of a patient's own processed serum albumin into a peripheral artery using percutaneous technique—yet the recent opportunities tagged under this code reflect broader occupational health, disability medical evaluation, and employee health benefit services. State and local governments are not soliciting the procedure itself but rather contracting for medical surveillance, independent medical evaluations, pharmacy benefit management, and Centers of Excellence networks that may encompass this or related interventions as part of larger clinical care coordination. The issuing bodies include county health systems, departments of transportation, municipal pension boards, and county commissioners' offices—diverse jurisdictions managing employee health programs, occupational safety compliance, and public safety retirement determinations rather than procurement of a discrete serum albumin infusion service.

The geographic spread includes Arizona (Phoenix), California (Long Beach and Santa Clara County), Washington State (Department of Transportation), Texas (Harris County), and Florida (Collier County). The most recent representative opportunities are the City of Phoenix Retirement Office RFP for independent medical evaluation services (due October 16, 2026), the Washington State Department of Transportation RFP for occupational medical surveillance (due October 9, 2026), and Santa Clara County Health System's non-exclusive qualified vendor pool for temporary health professional staffing (due October 7, 2026). The code exhibits weak signal for targeted pursuit; the mismatch between the nominal Commodity scope and actual state and local health-services contracting suggests either category miscoding or that this code is used as a catch-all tag for medical procedure and clinical assessment contracts that do not fit more granular taxonomy. Firms in occupational health, disability medical evaluation, or Centers of Excellence networks may see value in monitoring this code's usage, but the recent activity does not yet support a clear procurement pattern specific to autologous serum albumin infusion.